drugset / Trial / NCT00935467
Pharmacokinetics and Pharmacodynamics Study of Saxagliptin in Healthy Subjects
NaSingle-groupOpen-label
Summary
To characterize the steady-state pharmacokinetics (PK) of 2.5 mg saxagliptin administered twice daily with meals to healthy subjects
Timeline
- Start
- 2009-07
- Primary completion
- 2009-08
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SAXAGLIPTIN ANHYDROUS | Small molecule | 2.5 mg | Oral |